OS Therapies Appoints Frank Knuettel II As CFO

OS Therapies, Inc. (NYSE: OSTX) has appointed Frank Knuettel II as Chief Financial Officer (CFO) and Kerry Clem as Chief Commercial Officer (CCO). The company specializes in gene-edited, Listeria-based cancer immunotherapies.